Treace Medical Concepts Inc (TMCI) PT Lowered to $28 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Price: $4.50 +5.14%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Drew Ranieri lowered the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $28.00 (from $30.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Citi Upgrades Technogym SpA (TGYM:IM) (TCCHF) to Buy
- Procore Technologies, Inc (PCOR) PT Raised to $90 at BTIG
- Mahanagar Gas Limited (MAHGL:IN) PT Lowered to INR1,355 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
